Canigen^® DHPPi/L

FOR ANIMAL USE ONLY

Only for use by persons authorised thereto in terms of the Veterinary and Para-Veterinary Professions Act, 1982 (Act No. 19 of 1982).

 

Composition: Canigen DHPPi freeze-dried component: Attenuated canine distemper virus, attenuated canine adenovirus type 2, attenuated parvovirus and attenuated canine parainfluenza virus. Canigen L component as diluent: inactivated Leptospira suspension.

 

Warnings:

• Vaccinate healthy dogs only.
• Vaccination of pregnant or lactating bitches is not recommended.
• Occasional hypersensitivity reactions may be observed in some animals. Immediate treatment for anaphylactic shock (adrenaline, antihistamines and corticosteroids) must be given.
• Do not administer any corticosteroids or antiviral drugs preceding or following vaccination.
• Some dogs may be unable to develop or maintain an adequate immune response after vaccination due to various factors, such as incubating infectious disease, malnourishment, parasite infestation, or stress.
• Keep out of reach of children and uninformed persons.
• Although this vaccine has been extensively tested under a wide variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, contact the registration holder.

 

Precautions:

• It is recommended that animals be treated for external and internal parasites at least 10 days prior to vaccination.
• The vaccine should be administered in accordance with standard aseptic conditions for vaccination.
• Avoid exposure of the animal to infection for 21 days following vaccination.
• Use the vaccine immediately following reconstitution.
• Used needles, syringes and vials should be disposed of in a safe manner.

 

Directions for use: Use only as directed.

The vial containing the freeze-dried Canigen DHPPi component should be reconstituted with 1 ml vial of Canigen L component as diluent. Shake well. Use immediately after reconstitution. Administer 1 ml subcutaneously.

 

Primary vaccination: Puppies can be vaccinated from 8 weeks of age with 1 dose of Canigen DHPPi/L, followed by a second dose 3 weeks later.

Booster vaccination: Annual revaccination with a single dose of Canigen DHPPi/L.

High-risk situations: Canigen DHPPi can be administered in puppies from 6 weeks of age under circumstances where the risks of parvovirus and distemper maybe higher.

 

Virbac recommends the following standard vaccination protocol under normal circumstances:

Canigen DHPPi at 8 weeks of age

Canigen DHPPi/L at 11 weeks of age

Canigen DHPPi/LR at 14 weeks of age

 

Virbac recommends the following vaccination protocol in high-risk areas:

Canigen DHPPi at 6 weeks of age

Canigen DHPPi/L at 9 weeks of age

Canigen DHPPi/LR at 12 weeks of age

 

Presentation: 25 single-dose vials of freeze-dried Canigen DHPPi component and 25 vials of Canigen L component as diluent, packed in a plastic container with package insert enclosed.

 

Storage instructions: Store at 2-8 °C. Protect from light. Do not freeze.

 

Registration numbers:

South Africa Reg. No: G2839 (Act 36/1947).

Namibia Reg. No: V06/24.1/1140 NS0